Medroxyprogesterone Acetate: all 74 studies that test it

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular ClassificationRecruitingNCT07319429Phase 2/3
• Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and VomitingNot yet recruitingNCT07124195Phase 3
• A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)RecruitingNCT06979596Phase 2
• Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell DiseaseRecruitingNCT06665997Phase 4
• Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.Not yet recruitingNCT06637189Phase 4
• Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial HyperplasiaRecruitingNCT05675787Phase 2
• Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia PatientsRecruitingNCT05565573Phase 2/3
• Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-ANot yet recruitingNCT05326087Phase 3
• Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion PatientsCompletedNCT05505435Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive AgeCompletedNCT04682353Phase 1Results posted
• Postpartum Family PlanningTerminatedNCT03844633Phase 4Results posted
• A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046CompletedNCT03700658Phase 1Results posted
• Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health WorkersCompletedNCT03255941Early Phase 1Results posted
• Sayana® Press Extension StudyCompletedNCT03154125Phase 3Results posted
• Sayana Press UK Self-Injection StudyCompletedNCT03034057Phase 4Results posted
• Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory CycleCompletedNCT02817464Phase 1Results posted
• Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned ParenthoodCompletedNCT02509767Phase 4Results posted
• PK Study of Rifampicin Interactions With DMPA and Efavirenz in TBCompletedNCT02412436Phase 2Results posted
• Impact of Hormonal Contraception on HIV Acquisition and Transmission RiskCompletedNCT02357368Phase 4Results posted
• Belatacept 3 Month Post Transplant Conversion StudyCompletedNCT02213068Phase 4Results posted
• HSG and Tubal Patency StudyCompletedNCT02146248Not applicableResults posted
• Effect of Pre-operative Depo Medroxyprogesterone Acetate on Serum Anti-mullerian Hormone Level After Laparoscopic Ovarian Cystectomy of EndometriomasCompletedNCT01791413Phase 1/2Results posted
• Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and DepressionCompletedNCT01463202Phase 4Results posted
• Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent SubjectsCompletedNCT01461824Phase 3Results posted
• Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected WomenCompletedNCT01296152Phase 2Results posted
• DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal BleedingCompletedNCT01148420Phase 4Results posted
• PK of Depo SubQ Injected in the Upper ArmCompletedNCT01143207Not applicableResults posted
• Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial FunctionCompletedNCT01109979Phase 4Results posted
• Study of Self or Clinic Administration of DepoProveraCompletedNCT01019369Not applicableResults posted
• Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome)CompletedNCT00743574Not applicableResults posted
• Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast CancerCompletedNCT00577122Phase 2Results posted
• PROS-1-Male Hormonal Contraceptive Regimens on Prostate TissueCompletedNCT00490555Phase 2/3Results posted
• Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot StudyCompletedNCT06816901Phase 4
• Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative SurgeryCompletedNCT06145438Phase 3
• Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRKCompletedNCT05973253Phase 2/3
• Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation CyclesCompletedNCT05767086Not applicable
• Endometrial Biopsy in Progestin Contraceptive UsersCompletedNCT05760144Early Phase 1
• Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial CancerCompletedNCT05651282Phase 4
• Observation vs Progesterone Treatment for Management of Uterine Arteriovenous MalformationStatus unknownNCT05491343Phase 4
• Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIVActive, not recruitingNCT04910711Phase 4
• A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and AbdomenCompletedNCT04893798Phase 1
• Tranexamic Acid and Depot-Medroxyprogesterone Acetate for Perimenopausal Irregular Uterine BleedingCompletedNCT04710017Not applicable
• The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation CyclesStatus unknownNCT04654741Phase 4
• MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without AtypiaCompletedNCT03675139Phase 3
• The Kampala Women's Bone StudyCompletedNCT03464266Phase 4
• Depot Medroxyprogesterone Acetate as Emergency ContraceptionCompletedNCT03395756Early Phase 1
• Usefulness of Medroxyprogesterone Acetate in Follicular Phase in Oocyte Donors. Undergoing Ovarian StimulationCompletedNCT03300960Phase 3
• Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEPCompletedNCT03197961Early Phase 1
• Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic CauseCompletedNCT02943655Phase 3
• Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic PatientsCompletedNCT02894151Phase 2
• Apoptotic Signaling Pathways in Rats With Endometrial HyperplasiaCompletedNCT02872818Phase 4
• The Evidence for Contraceptive Options and HIV Outcomes TrialCompletedNCT02550067Not applicable
• Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic PatientsCompletedNCT02534688Phase 4
• The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea RatesTerminatedNCT02449161Phase 3
• Endometrial Shedding Prior to Ovulation Induction Pilot StudyCompletedNCT02340013Phase 4
• The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting HysterectomyStatus unknownNCT02335203Phase 2
• Sayana® Press Self-injection Study in MalawiCompletedNCT02293694Not applicable
• Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected WomenCompletedNCT02103660Phase 4
• Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH AgonistTerminatedNCT01776203Phase 4
• Postmenopausal Women,Treatment of Sleep Apnea and Co-morbiditiesCompletedNCT01472315Phase 2/3
• Depot Contraception With and Without Lopinavir/RitonavirWithdrawnNCT01231451Phase 1
• Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in MalawiCompletedNCT01191203Not applicable
• A Study Comparing Mirena and Systemic Progestin for Endometrial HyperplasiaCompletedNCT01074892Phase 4
• Efficacy of Injectable Contraceptive and Oral Contraceptive Administered After Surgical Treatment of Endometriosis With PainCompletedNCT01056042Phase 4
• Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate AdenocarcinomaCompletedNCT01011751Phase 3
• Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal WomenCompletedNCT00830414Phase 1
• Impact of Different Contraceptives on the Immune System of HIV Infected Women in ZambiaCompletedNCT00807625Phase 2
• Hormonal Replacement Therapy and Small Artery FunctionCompletedNCT00564031Phase 3
• Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal WomenCompletedNCT00543634Phase 1
• Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian FailureWithdrawnNCT00370019Phase 2
• Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate PrognosisCompletedNCT00291369Phase 3
• Estrogen, HDL, and Coronary Heart Disease in WomenCompletedNCT00083824Phase 2/3
• Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected WomenCompletedNCT00016601Not applicable
• Safety of Estrogens in Lupus: Hormone Replacement TherapyTerminatedNCT00000419Phase 3

← Medroxyprogesterone Acetate overview